Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Abemaciclib combined with endocrine therapy improves OS in high-risk HR+, HER2− early breast cancer

Prof Stephen Johnston - The Royal Marsden, London, UK
Abemaciclib combined with endocrine therapy improves OS in high-risk HR+, HER2− early breast cancer ( Prof Stephen Johnston - The Royal Marsden, London, UK )
19 Oct 2025

Durvalumab combined with FLOT improves survival in resectable gastric and GEJ adenocarcinoma

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA
Durvalumab combined with FLOT improves survival in resectable gastric and GEJ adenocarcinoma ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Oct 2025

NSCLC brain metastases: TTFields after SRS delays intracranial progression without affecting QoL

Dr Vinai Gondi - Northwestern Medicine West Region and Proton Center, Illinois, USA
NSCLC brain metastases: TTFields after SRS delays intracranial progression without affecting QoL ( Dr Vinai Gondi - Northwestern Medicine West Region and Proton Center, Illinois, USA )
8 Oct 2025

Proton vs photon radiotherapy shows similar patient-reported quality of life in breast cancer patients

Dr Shannon MacDonald - Southwest Florida Proton Center, Florida, USA
Proton vs photon radiotherapy shows similar patient-reported quality of life in breast cancer patients ( Dr Shannon MacDonald - Southwest Florida Proton Center, Florida, USA )
8 Oct 2025

Apalutamide and salvage radiotherapy benefits luminal B subtype prostate cancer

Prof Daniel Spratt - University Hospitals Cleveland Medical Center, Cleveland, USA
Apalutamide and salvage radiotherapy benefits luminal B subtype prostate cancer ( Prof Daniel Spratt - University Hospitals Cleveland Medical Center, Cleveland, USA )
8 Oct 2025

ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer

Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA
ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer ( Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA )
8 Oct 2025

Non-clear cell renal cell carcinoma: Management of papillary RCC

Prof Camillo Porta and Prof Laurence Albiges
Non-clear cell renal cell carcinoma: Management of papillary RCC ( Prof Camillo Porta and Prof Laurence Albiges )
7 Oct 2025

Bladder cancer updates from the first half of 2025

Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone and Dr Benjamin Pradere
Bladder cancer updates from the first half of 2025 ( Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone and Dr Benjamin Pradere )
26 Sep 2025

CURB phase II trial: Tumour burden predicts survival after SBRT in NSCLC oligoprogression

Dr Matthew McMillan - Memorial Sloan-Kettering Cancer Center, New York, USA
CURB phase II trial: Tumour burden predicts survival after SBRT in NSCLC oligoprogression ( Dr Matthew McMillan - Memorial Sloan-Kettering Cancer Center, New York, USA )
22 Sep 2025

WCLC 2025: Latest in EGFR positive NSCLC

Prof Enriqueta Felip, Dr Antonio Passaro, Dr Alex Spira and Prof Ignacio Gil-Bazo
WCLC 2025: Latest in EGFR positive NSCLC ( Prof Enriqueta Felip, Dr Antonio Passaro, Dr Alex Spira and Prof Ignacio Gil-Bazo )
9 Sep 2025

Dose escalation of RG6344 demonstrates safety and promising activity in BRAF V600E solid tumours

Dr Maria Vieito - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Dose escalation of RG6344 demonstrates safety and promising activity in BRAF V600E solid tumours ( Dr Maria Vieito - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
1 Sep 2025

Treatment management of favourable risk and very favourable risk patients

Dr Guillermo de Velasco and Dr Marco Maruzzo
Treatment management of favourable risk and very favourable risk patients ( Dr Guillermo de Velasco and Dr Marco Maruzzo )
1 Sep 2025